José Antonio García Erce: Growing Immunoglobulin Use Challenges of Supply and Sustainability
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared a post on LinkedIn:
”Increasing consumption of immunoglobulins.
To infinity and beyond?
Although it has been possible to increase in recent years by 40% the shipment of plasma to Grifols for the industrial fractionation of hemoderivados, with a similar growth in production, thanks, among other measures, to the increase of more than 1000% of aféresis in 10 years, and to almost double the plasmaféresis every two years…. It is impossible to be self-sufficient!
With the current model, without a change in the paradigm, if the growth of the consumo is much higher than the supply, coming from donantes unpaid and uncompensated volunteers.
The graphs show the growth of patients treated with inmunoglobulinas and of the units consumed in the public centers of the Autonomous Community of Navarre.
Where is the limit?”
Stay updated with Hemostasis Today.
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
-
Jun 9, 2026, 15:34Shanon Marie Corsino: Nationwide Insights into Cancer-Associated Thrombosis in Filipino Patients
-
Jun 9, 2026, 15:20Murtuza Ali: Types of Blood Transfusions – A Quick Clinical Guide
-
Jun 9, 2026, 15:18Mital Jhaveri: TRACK Trial Findings Highlight the Unique Challenges of Advanced CKD